Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2008
11/13/2008WO2008134876A1 Cancerous disease modifying antibodies
11/13/2008WO2008134806A1 Mycobacterium antigens
11/13/2008WO2008117087A3 Photonic biosensor arrays
11/13/2008WO2008116150A3 Ileal pouch-anal anastomosis (ipaa) factors in the treatment of inflammatory bowel disease
11/13/2008WO2008115478A3 Method of cancer detection and treatment
11/13/2008WO2008115420A3 Methods for detecting molecular interactions within cells using combination of inducible promoters and biosensors
11/13/2008WO2008112164A3 Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
11/13/2008WO2008112127A3 Functional arrays for high throughput characterization of regulatory elements in untranslated regions of genes
11/13/2008WO2008110593A3 Method and markers for the diagnosis of renal diseases
11/13/2008WO2008110247A8 Method for identifying the agonistic activity of a target compound on a potassium channel
11/13/2008WO2008105918A3 Methods of detection using acousto-mechanical detection systems
11/13/2008WO2008098787A3 Cd83 as a molecular switch for the induction of regulatory (immunosuppressive) t-cells
11/13/2008WO2008097632A3 Methods for determining splice variant types and amounts
11/13/2008WO2008096225A3 Drug detection kit and method
11/13/2008WO2008096082A3 Method for measuring the concentration of activated factor vii (fviia) in a sample
11/13/2008WO2008094964A3 Cancer therapy prognosis
11/13/2008WO2008094713A3 Detection and treatment of neurodegenerative tauopathies
11/13/2008WO2008092430A3 Method and device for the contactless detection of an installed position of a component
11/13/2008WO2008092002A3 Compositions and methods for treating and diagnosing pancreatic cancer
11/13/2008WO2008091598A3 CONFORMATION AND ACTIVITY OF Gβ5 COMPLEXES
11/13/2008WO2008090416A3 Tumor suppressor functions of the rb-skp2 pathway are disabled in high risk but functional in low-risk neuroblastomas
11/13/2008WO2008086034A3 Antibody-based gamma-hydroxybutyrate (ghb) detection method and device
11/13/2008WO2008082438A3 Chd5 is a novel tumor suppressor gene
11/13/2008WO2008075174A3 Lysosomal associated membrane protein (lamp) - like polypeptide, ligands to the same, and use of the same in the frame of detection and purification of human plasmacytoid dendritic cells
11/13/2008WO2008070727A3 Recombinant antibodies against hepatitis c virus and methods of obtaining and using same
11/13/2008WO2008067003A3 A method to detect virus related immunological markers for the diagnosis of respiratory tract infections
11/13/2008WO2008063758A3 Multifunctional encoded particles for high-throughput analysis
11/13/2008WO2008063306A3 Method to identify epitopes
11/13/2008WO2008063225A3 Systems and methods for monitoring travel conditions
11/13/2008WO2008061020A9 Methods of treating, diagnosing or detecting cancer
11/13/2008WO2008060602A3 Polymorphisms in the urocortin 3 gene and their associations with marbling and subcutaneous fat depth in beef cattle
11/13/2008WO2008058103A3 Assays useful in determining cd38 inhibition
11/13/2008WO2008051761A3 Assay for cardiac troponin autoantibodies
11/13/2008WO2008051374A3 Rapid screening of oral squamous cell carcinoma
11/13/2008WO2008048773A3 Models of atherosclerosis, hyperlipidemia, lipoprotein oxidation and blood vessel inflammation and methods for making and using them
11/13/2008WO2008045799A3 Electrochemical nanosensors for biomolecule detection
11/13/2008WO2008042436A3 Biomarkers and assays for the treatment of cancer
11/13/2008WO2008042024A3 Neuroactive fragments of app
11/13/2008WO2008030538A3 Cancer stem cell-targeted cancer therapy
11/13/2008WO2008029031A3 Pharmacodiagnostic test targeting oncology
11/13/2008WO2008027800A3 Method for enhancing the efficacy of antigen specific tumor immunotherapy
11/13/2008WO2008024413A3 Tissue culture system for production of hepatitis c virus
11/13/2008WO2008021976A3 Anti-interferon alpha monoclonal antibodies and methods for use
11/13/2008WO2008021614A3 Coded particle arrays for high throughput analyte analysis
11/13/2008WO2008021290A3 Organ-specific proteins and methods of their use
11/13/2008WO2008021055A3 System and method for detecting specific binding reactions using magnetic labels
11/13/2008WO2008019315A3 Improved pre-implantation genetic diagnosis test
11/13/2008WO2008019299A3 Image processing method for a microscope system
11/13/2008WO2008014450A3 Model taste cells and methods of use for identifying modulators of taste sensation
11/13/2008WO2008008248A3 Biosurfaces for receiving, retaining & displaying biological moieties
11/13/2008WO2007146385A3 Albumin-bound protein/peptide complex as a biomarker for disease
11/13/2008WO2007145988A3 System for controlling fluid movement between a sample pad and a test strip
11/13/2008WO2007145936A3 System and methods for evaluating the efficacy of appetite-affecting drugs
11/13/2008WO2007133835A3 Ras mutation and compositions and methods related thereto
11/13/2008WO2007131135A3 Evaluating genetic disorders
11/13/2008WO2007127367A3 Method of prediction of the three-dimensional conformation of flexible proteins
11/13/2008WO2007122369A8 Novel tumour suppressor
11/13/2008WO2007106598A3 Devices and methods for detecting cells and other analytes
11/13/2008WO2007101960A3 Device and method for identifying a fuel
11/13/2008WO2007101094A3 Bbs10 related diagnostic methods and reagents for bardet-biedl syndrome
11/13/2008WO2007092627A3 Detection of cancer by elevated levels of bcl-2
11/13/2008WO2007019244A3 Continuous range hydrogen sensor
11/13/2008WO2006137838A3 Methods and compositions for diagnosing and preventing a group b streptococcal infection
11/13/2008WO2006105417A3 Compositions and methods for the identification, assessment, prevention, and therapy of neurological diseases, disorders and conditions
11/13/2008WO2006025983A3 Labeled substrate conjugates for identifying enzyme inhibitors
11/13/2008WO2004080283A3 Type 1 ryanodine receptor-based methods
11/13/2008US20080281531 Method for Diagnosing Depression
11/13/2008US20080281530 Genomic data processing utilizing correlation analysis of nucleotide loci
11/13/2008US20080281529 Genomic data processing utilizing correlation analysis of nucleotide loci of multiple data sets
11/13/2008US20080281528 System and Method for Environmental Sampling and Diagnostic Evaluation
11/13/2008US20080281177 method of making an electrochemical sensor
11/13/2008US20080281176 Method of making an electrochemical sensor
11/13/2008US20080281175 Method of making an electrochemical sensor
11/13/2008US20080281064 Novel Glycopolymers, Uses Thereof, and Monomers Useful for Preparation Thereof
11/13/2008US20080280938 Screening Method
11/13/2008US20080280863 Concurrent administering by mouth a corticosteroid and tricyclic antidepressant compound; immunoinflamamtory disorders; antiarthritic agents; skin disorders; inflammatory bowel disorders; Crohn's disorders; autoimmune disease; asthma; multiple sclerosis; diabetes; lupus
11/13/2008US20080280844 Methods and compositions for the diagnosis and treatment of ewing's sarcoma
11/13/2008US20080280833 amino acid motif GAAG; polypeptide that inhibits cell migration, cell adhesion, cell proliferation and/or cell differentiation; anticancer; adenocarcinoma, leukemia, lymphoma, or myeloma; inhibitor of chemotaxis
11/13/2008US20080280822 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer
11/13/2008US20080280782 Method for noncovalently immobilizing a biomolecule on a solid substrate and microarray produced according to the method
11/13/2008US20080280778 Binding reagents that contain small epitope binding molecules
11/13/2008US20080280776 Method and apparatus for detection of molecules using a sensor array
11/13/2008US20080280774 Methods and Systems for Diagnosis, Prognosis and Selection of Treatment of Leukemia
11/13/2008US20080280770 Method of isolating biologically active chemical compounds from a chemical compound library
11/13/2008US20080280769 Selective and dual-action p53/mdm2/mdm4 antagonists
11/13/2008US20080280768 Reagents and Methods for Predicting Drug Resistance
11/13/2008US20080280378 Grading of Immune Responses
11/13/2008US20080280377 Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
11/13/2008US20080280376 Method of Evaluation of the Relative Risk of Developing Atherosclerosis in Patients
11/13/2008US20080280375 Arsenic-Specific Stain for Identifying Arsenic-Treated Wood
11/13/2008US20080280371 Using acoustic wave device to measure change in molecular weight and determine concentration of carbamide in solution
11/13/2008US20080280370 Methods and compositions for detecting glyphosate and metabolites thereof
11/13/2008US20080280369 Sample suspected of containing the target polynucleotide is contacted with a polycationic multichromophore and a sensor polynucleotide complementary to the target polynucleotide; kits
11/13/2008US20080280368 Parasitic helminth cuticlin proteins and uses thereof
11/13/2008US20080280367 Using nucleotide-binding oligomerization domain containing 2 (NOD2) expression profile as evaluative tool in determining treatment dosages gastrointestinal distress
11/13/2008US20080280366 Using sodium bromide to enhance formation of luminescent clusters and measure presence of dissolved lead in aqueous solutions
11/13/2008US20080280365 Fluidic device for determining hemocrit of blood
11/13/2008US20080280364 Control of Apoptosis By Controlling the Propensity of Ceramide Channel Formation
11/13/2008US20080280353 Hybrid nucleic acid assembly
11/13/2008US20080280351 Tissue cassette assembly for cell block embedding
1 ... 1351 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 ... 3937